The Explainer: What is antibiotic resistance and why should we be concerned about it?

THE TERM ANTIBIOTIC resistance might sound a bit futuristic – but it’s something that’s very much an issue in the here and now.

As we explore in this week’s The Explainer podcast, it refers to certain bacteria becoming immune to the antibiotics that are usually used to treat them. This can result in health issues for patients, and dangerous superbugs.

If you want to get up to speed on what antibiotic resistance is, what it means for you as an individual, and what is being done about it, this episode is for you.

Maria Delaney, investigative reporter with Noteworthy, is joined by Professor of biology Fiona Walsh from Maynooth University to talk us through the topic.

Click link for Podcast: Podcast

GMIT/HSE team present findings of first survey of students’ knowledge of antibiotic use

“Awareness of antibiotic use and antibiotic resistance in a west of Ireland third-level student population”

The survey “Awareness of antibiotic use and antibiotic resistance in a west of Ireland third-level student population” was carried out this year (2019) by Dr Debbie Corcoran, Dr Sheila Faherty and Sandy Bakankio BSc, Department of Biopharmaceutical and Medical Science, GMIT, in collaboration with members of the HSE’s national Antimicrobial Resistance and Infection Control team (AMRIC) – surveillance scientist Maria Molloy and Communications Manager Audrey Lambourn (HCAI).

The study shows there is misuse of antibiotics, with 35% of the study population using leftover antibiotics, 1.2% of participants’ obtaining antibiotics online and 1.2% obtaining antibiotics abroad. The study also highlighted a lack of knowledge in this demographic in relation to the treatment of sexually transmitted infections.

Click link: Survey

CDC releases 2019 Antibiotic Resistance Threats Report

The Centers for Disease Control and Prevention’s 2019 AR Threats Report shows that antibiotic-resistant bacteria and fungi cause more than 2.8 million infections and 35,000 deaths in the United States each year—that’s at least one infection every 11 seconds and one death from antibiotic resistance every 15 minutes. The new report shows that there were nearly twice as many annual deaths from antibiotic resistance as CDC originally reported in 2013. Since then, prevention efforts have reduced deaths by 18 percent overall and by nearly 30 percent in hospitals. Without continued vigilance, this progress may be challenged by the increasing burden of some infections.

Click link: Report

Antimicrobial and Antihelmintic Resistance Conference

27 November 2019
Event Time 8 am
Venue Tullamore Court Hotel, O’Moore St, Tullamore, Co. Offaly

ONE HEALTH- Awareness to Action

The forthcoming ONE HEALTH – Awareness to Action Antimicrobial and Anthelmintic Resistance Conference focusses on creating a greater awareness amongst farmers and professionals serving the agri-food industry. There will also be an emphasis on clear concise practical actions which can be taken on Irish farms to reduce their need to use antimicrobials and anthelmintics. The morning session sets the scene and the challenges facing farmers and professionals with the national lead for the HSE for antimicrobial resistance, Professor Martin Cormican, (NUIG) as a key note speaker. Martin Kavanagh, Veterinary consultant, will describe the Scandinavian experience of farming without antibiotics, while Dr Aine Regan (Teagasc) will describe consumer demands for antimicrobial free food. Dr Dearbhaile Morris (NUIG) will highlight the role of the environment in the development and spread of AMR. Four Irish dairy, beef, sheep and pig producers will describe their experience of farming with reduced dependence on antimicrobials.

Click Link: Conference

New EU MEP Interest Group on AMR

The AMR MEP Interest Group is the only dedicated group of MEPs working together to take action to combat one of the greatest global health threats of our time. Participating MEPs are concerned by the rise in drug-resistant infections and believe that European cooperation is vital. No single country can tackle this cross-border threat alone. Members of the group are committed to:

•Ensure that AMR remains high on the EU policy agenda during the new EU mandate and that well-coordinated and resourced actions at EU and national level are undertaken, aligned with the global work led by the WHO, UN agencies and other actors

•Stress the need for urgent action to tackle AMR through a multi-sectoral ‘One Health’ approach which addresses human, animal and environmental health

Click Link: AMR Group

Roadmap for action on antimicrobial resistance (AMR) – EU

5 key strategies and targets to tackle AMR

The signatories of this Roadmap call for the implementation of 5 key strategies and targets to tackle AMR:

1. Set targets and performance indicators

2. Help countries mobilise resources for better implementation of national AMR policies

3. Close the existing collaboration gap between civil society and EU policy-makers

4. Put prevention at the heart of AMR policy-making

5. Tackle the environmental dimension of AMR in the framework of the European Green Deal

Click Link: Roadmap

AMR Stakeholder Network

The AMR Stakeholder Network brings together 80 leading organisations and individuals committed to tackling Antimicrobial Resistance (AMR) at national, regional and European level, covering all dimensions of the ‘One Health’ approach.

Click Link. AMR Stakeholder Network